Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 53 citations
Electronic publication date
October 16, 2015

View on Pubmed.gov 25780292 | View on doi.org 10.3748/wjg.v21...

Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.

Search for publications in this journal World J Gastroenterol - 21(10):2949-58

Abstract

AIM

To investigate the function and mechanism of miR-133a in gastric cancer (GC) and its relationship with clinicopathological characteristics of GC.

METHODS

A total of 105 GC patients who underwent surgical resection as primary treatment were selected for this study. Real-time quantitative reverse transcriptase polymerase chain (qRT-PCR) was used to examine the expression levels of miR-133a in human GC and adjacent non-tumor tissues, as well as in GC cell lines (SGC-7901, BGC-823, MGC-803, and AGS) and a human gastric mucosal epithelial cell line (GES-1). The biological role of miRNA (miR)-133a was assessed in the GC cell lines using MTT, apoptosis, migration and invasion, and colony formation assays, and xenograft tumorigenesis. qRT-PCR and western blot analyses were used to evaluate the potential target gene expression of miR-133a. Pearson's correlation was calculated to evaluate the correlation between miR-133a and insulin-like growth factor 1 receptor (IGF1R) expression. The regulation of IGF1R by miR-133a was verified using the luciferase reporter assay.

RESULTS

In 80% of the 105 GC patients, the mean expression of miR-133a was significantly downregulated in tumor tissues compared with adjacent normal tissues (1.215 ± 0.1477 vs 3.093 ± 0.4104, P < 0.0001). Downregulation of miR-133a was significantly correlated with the degree of differentiation (P = 0.01), local invasion (P = 0.001) and TNM stage (P = 0.02) in GC patients. Compared with a control construct, forced expression of miR-133a in GC cell lines inhibited proliferation (0.4787 ± 0.0219 vs 0.7050 ± 0.0147, P = 0.0013 in SGC-7901 cells; and 0.5448 ± 0.0085 vs 0.7270 ± 0.0084, P = 0.001 in MGC-803 cells); migration (0.6333 ± 0.0233 vs 1.037 ± 0.0584, P = 0.003 in SGC-7901 cells; 0.6126 ± 0.0311 vs 1.024 ± 0.0456, P = 0.0017 in MGC-803 cells); and invasion (0.613 ± 0.0399 vs 1.033 ± 0.0278, P = 0.0013 in SGC-7901 cells; 0.7433 ± 0.0221 vs 1.017 ± 0.0311, P = 0.002 in MGC-803 cells). It also induced apoptosis (18.19% ± 0.2483% vs 5.887% ± 0.3837%, P < 0.0001 in SGC-7901 cells; 22.69% ± 0.7846% vs 9.347% ± 0.3012%, P < 0.0001 in MGC-803 cells). Furthermore, miR-133a inhibited tumor growth and xenograft tumorigenesis of SGC -7901 cells in vivo. In addition, we identified IGF1R as a regulatory target of miR-133a in GC.

CONCLUSION

This study suggests that miR-133a is downregulated in GC and functions as a tumor suppressor in vitro and in vivo partly by repressing IGF1R.

References

Mol Cancer Res. 2013 Sep;11(9):1051-60

J Gastroenterol Hepatol. 2009 Apr;24(4):652-7

FEBS J. 2013 Aug;280(16):3962-74

Br J Cancer. 2012 Jan 17;106(2):405-13

Cited by 53 citations (total)

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.

Electronic publication date October 17, 2017

Search for publications in this journal BMC Cancer

Zuzana Vojtechova [...] Ruth Tachezy et al.

BACKGROUND

Better insights into the molecular changes involved in virus-associated and -independent head and neck cancer may advance our knowledge of...

Journal Article

Is Associated with Expression through Promoter Methylation in Gastric Carcinogenesis.

Electronic publication date October 3, 2018

Search for publications in this journal Gut Liver

Joo Hyun Lim [...] Hyun Chae Jung et al.

BACKGROUND/AIMS

To investigate whether eradication can reverse epigenetic silencing of microRNAs (miRNAs) which are associated with -induced gastric carcinogenesis.

METHODS

We examined...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances